ADEA Stock Analysis: ADEIA | NASDAQ
Software - Application | NASDAQ, USA | Market Cap: 2.862m USD | 12M Return: 97.2% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 39.7M
EPS Trend: 24.3%
Qual. Beats: 0
Rev. Trend: 43.9%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Adeia Inc. is a media and semiconductor intellectual property (IP) licensing platform company that monetizes patent portfolios through royalty agreements with technology and entertainment industry customers. The IP licensing model generates revenue by allowing manufacturers and service providers to use patented technologies in exchange for ongoing fees, without the need to produce or sell physical products directly. The company operates across the United States, Asia, Canada, Europe, the Middle East, and other international markets.
Adeias licensing activities span a broad range of customer segments, including multichannel video programming distributors (cable, satellite, and telecom TV providers), over-the-top streaming services, content providers and media companies, consumer electronics manufacturers (such as smart TV, streaming device, and gaming console producers), semiconductor companies (memory, logic, sensors, and RF devices), and social media platforms. All intellectual property is licensed under the Adeia brand.
The company was formerly known as Xperi Holding Corporation before adopting the Adeia name, was incorporated in 2019, and is headquartered in San Jose, California. It trades on NASDAQ under the ticker ADEA and is classified within the Information Technology sector, reflecting its position at the intersection of media technology and semiconductor intellectual property.
- Semiconductor IP licensing revenue accelerates with memory and logic chip demand
- Major streaming and TV manufacturer license renewals drive royalty growth
- Patent litigation settlements and verdicts boost quarterly cash flow
| Net Income: 122.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.15 > 0.02 and ΔFCF/TA -1.91 > 1.0 |
| NWC/Revenue: 43.36% < 20% (prev 45.64%; Δ -2.29% < -1%) |
| CFO/TA 0.16 > 3% & CFO 159.4m > Net Income 122.0m |
| Net Debt (284.6m) to EBITDA (253.7m): 1.12 < 3 |
| Current Ratio: 3.44 > 1.5 & < 3 |
| Outstanding Shares: last quarter (114.2m) vs 12m ago 1.05% < -2% |
| Gross Margin: 86.99% > 18% (prev 83.25%; Δ 3.73% > 0.5%) |
| Asset Turnover: 44.08% > 50% (prev 34.98%; Δ 9.09% > 0%) |
| Interest Coverage Ratio: 5.05 > 6 (EBIT TTM 193.3m / Interest Expense TTM 38.3m) |
| A: 0.20 (Total Current Assets 281.3m - Total Current Liabilities 81.7m) / Total Assets 1.00b |
| B: 0.11 (Retained Earnings 109.4m / Total Assets 1.00b) |
| C: 0.18 (EBIT TTM 193.3m / Avg Total Assets 1.04b) |
| D: 0.87 (Book Value of Equity 466.6m / Total Liabilities 535.8m) |
| Altman-Z'' = 3.82 = AA |
| DSRI: 0.69 (Receivables 157.0m/187.3m, Revenue 460.5m/380.3m) |
| GMI: 0.96 (GM 83.25% / 86.99%) |
| AQI: 0.95 (AQ_t 0.71 / AQ_t-1 0.74) |
| SGI: 1.21 (Revenue 460.5m / 380.3m) |
| TATA: -0.04 (NI 122.0m - CFO 159.4m) / TA 1.00b) |
| Beneish M = -3.20 (Cap -4..+1) = AA |
As of July 28, 2026, the stock is trading at USD 26.07 with a total of 1,026,493 shares traded. Over the past week, the price has changed by -0.53%, over one month by -21.00%, over three months by -13.32% and over the past year by +97.21%.
Current recommended Stop Loss: 24.20 (which is 7.2% or 1.1 ATR below the current price).
ADEIA has received a consensus analysts rating of 4.33. Therefore, it is recommended to buy ADEA.
- StrongBuy: 1
- Buy: 2
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 37 | 41.9% |
P/E Trailing = 23.8073
P/E Forward = 18.9394
P/S = 6.2154
P/B = 6.1344
P/EG = 1.5095
Revenue TTM = 460.5m USD
EBIT TTM = 193.3m USD
EBITDA TTM = 253.7m USD
Long Term Debt = 370.3m USD (from longTermDebt, last quarter)
Short Term Debt = 21.0m USD (from shortTermDebt, last quarter)
Debt = 400.4m USD (corrected: LT Debt 370.3m + ST Debt 21.0m) + Leases 9.10m
Net Debt = 284.6m USD (calculated: Debt 400.4m - CCE 115.8m)
Enterprise Value = 3.15b USD (2.86b + Debt 400.4m - CCE 115.8m)
Interest Coverage Ratio = 5.05 (Ebit TTM 193.3m / Interest Expense TTM 38.3m)
EV/FCF = 20.93x (Enterprise Value 3.15b / FCF TTM 150.3m)
FCF Yield = 4.78% (FCF TTM 150.3m / Enterprise Value 3.15b)
FCF Margin = 32.65% (FCF TTM 150.3m / Revenue TTM 460.5m)
Net Margin = 26.50% (Net Income TTM 122.0m / Revenue TTM 460.5m)
Gross Margin = 86.99% ((Revenue TTM 460.5m - Cost of Revenue TTM 59.9m) / Revenue TTM)
Gross Margin QoQ = 84.33% (prev 92.23%)
Tobins Q-Ratio = 3.14 (Enterprise Value 3.15b / Total Assets 1.00b)
Interest Expense / Debt = 9.56% (Interest Expense 38.3m / Debt 400.4m)
Taxrate = 21.27% (33.0m / 155.0m)
NOPAT = 152.2m (EBIT 193.3m * (1 - 21.27%))
Current Ratio = 3.44 (Total Current Assets 281.3m / Total Current Liabilities 81.7m)
Debt / Equity = 0.86 (Debt 400.4m / totalStockholderEquity, last quarter 466.6m)
Debt / EBITDA = 1.12 (Net Debt 284.6m / EBITDA 253.7m)
Debt / FCF = 1.89 (Net Debt 284.6m / FCF TTM 150.3m)
Total Stockholder Equity = 440.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 11.68% (Net Income 122.0m / Total Assets 1.00b)
RoE = 27.68% (Net Income TTM 122.0m / Total Stockholder Equity 440.9m)
RoCE = 23.82% (EBIT 193.3m / Capital Employed (Equity 440.9m + L.T.Debt 370.3m))
RoIC = 16.56% (NOPAT 152.2m / Invested Capital 918.7m)
WACC = 11.82% (E(2.86b)/V(3.26b) * Re(12.42%) + D(400.4m)/V(3.26b) * Rd(9.56%) * (1-Tc(0.21)))
Discount Rate = 12.42% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 33.75 | Cagr: 0.54%
[DCF] Terminal Value 61.34% ; FCFF base≈163.7m ; Y1≈143.6m ; Y5≈116.0m
[DCF] Fair Price = 8.21 (EV 1.19b - Net Debt 284.6m = Equity 905.3m / Shares 110.3m; r=11.82% [WACC]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 24.33 | EPS CAGR: 4.14% | SUE: 0.52 | # QB: 0
Revenue Correlation: 43.92 | Revenue CAGR: 4.25% | SUE: 0.43 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.31 | Chg30d=-13.12% | Revisions=-50% | Analysts=4
EPS next Quarter (2026-09-30): EPS=0.35 | Chg30d=-5.97% | Revisions=-50% | Analysts=4
EPS current Year (2026-12-31): EPS=1.42 | Chg30d=-1.11% | Revisions=+17% | GrowthEPS=-13.9% | GrowthRev=-5.9%
EPS next Year (2027-12-31): EPS=1.55 | Chg30d=+3.45% | Revisions=+40% | GrowthEPS=+9.0% | GrowthRev=+7.3%
[Analyst] Revisions Ratio: -21% (up=4, down=7)